17-4499263-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2
The NM_001124758.3(SPNS2):c.216C>T(p.Pro72=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00101 in 1,474,560 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0051 ( 6 hom., cov: 32)
Exomes 𝑓: 0.00055 ( 7 hom. )
Consequence
SPNS2
NM_001124758.3 synonymous
NM_001124758.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.917
Genes affected
SPNS2 (HGNC:26992): (SPNS lysolipid transporter 2, sphingosine-1-phosphate) The protein encoded by this gene is a transporter of sphingosine 1-phosphate, a secreted lipid that is important in cardiovascular, immunological, and neural development. Defects in this gene are a cause of early onset progressive hearing loss. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 17-4499263-C-T is Benign according to our data. Variant chr17-4499263-C-T is described in ClinVar as [Benign]. Clinvar id is 3044738.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=0.917 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00508 (770/151512) while in subpopulation AFR AF= 0.0177 (731/41358). AF 95% confidence interval is 0.0166. There are 6 homozygotes in gnomad4. There are 363 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 6 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SPNS2 | NM_001124758.3 | c.216C>T | p.Pro72= | synonymous_variant | 1/13 | ENST00000329078.8 | |
SPNS2 | XR_007065260.1 | n.383C>T | non_coding_transcript_exon_variant | 1/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SPNS2 | ENST00000329078.8 | c.216C>T | p.Pro72= | synonymous_variant | 1/13 | 1 | NM_001124758.3 | P1 | |
SPNS2-AS1 | ENST00000416958.1 | n.48+364G>A | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00508 AC: 769AN: 151404Hom.: 6 Cov.: 32
GnomAD3 genomes
AF:
AC:
769
AN:
151404
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000540 AC: 43AN: 79668Hom.: 1 AF XY: 0.000373 AC XY: 17AN XY: 45578
GnomAD3 exomes
AF:
AC:
43
AN:
79668
Hom.:
AF XY:
AC XY:
17
AN XY:
45578
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000546 AC: 722AN: 1323048Hom.: 7 Cov.: 32 AF XY: 0.000501 AC XY: 327AN XY: 652112
GnomAD4 exome
AF:
AC:
722
AN:
1323048
Hom.:
Cov.:
32
AF XY:
AC XY:
327
AN XY:
652112
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00508 AC: 770AN: 151512Hom.: 6 Cov.: 32 AF XY: 0.00490 AC XY: 363AN XY: 74024
GnomAD4 genome
AF:
AC:
770
AN:
151512
Hom.:
Cov.:
32
AF XY:
AC XY:
363
AN XY:
74024
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
SPNS2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 25, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at